Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Matthew R. Sydes"'
Autor:
Noel W. Clarke, Duncan C. Gilbert, Ruth E Langley, Trinh Duong, Anna Bara, Matthew R. Sydes, Paul D. Abel, Max Parmar, Nicholas D. James
Publikováno v:
BJU international. 121(5)
Androgen deprivation therapy (ADT) remains a cornerstone of the management of prostate cancer. The addition of ADT to radiotherapy improves disease-free and overall survival in the locally advanced setting and ADT forms the backbone onto which additi
Publikováno v:
BJU international. 118(2)
Publikováno v:
BJU International. 106:946-948
Autor:
George N. Thalmann, J. Martin Russell, Matthew R. Sydes, Mahesh K. B. Parmar, Johann S. de Bono, Chris Parker, Alastair W. S. Ritchie, David P. Dearnaley, Noel W. Clarke, Malcolm David Mason, Daniel M. Aebersold, Nicholas D. James
Publikováno v:
BJU international. 111(5)
Many patients presenting with metastatic prostate cancerask whether they should have treatment to the prostateitself in addition to their hormone therapy. This question isincreasingly common and there is a growing sense thatthese inquiring patients m
Autor:
Matthew R. Sydes, John Dwyer, David P. Dearnaley, John Anderson, Noel W. Clarke, John R. W. Masters, Jim Stansfeld, Nicholas D. James, Rachel C Morgan, Rick Popert, Mahesh K.B. Parmar, Malcolm David Mason, Karen Sanders
Publikováno v:
BJU international. 103(4)
There is a need to improve the outcomes for men with high-risk localised, nodal or metastatic prostate cancer, or with aggressively relapsing disease after initial therapy for local disease. This group of men is currently managed with long-term hormo
Autor:
Heather Payne, Matthew R. Sydes, Kilian Mellon, Jim Stansfeld, Noel W. Clarke, W. Parulekar, Charles Catton, Colleen Savage, Mahesh K. B. Parmar, Claire Murphy, Howard Kynaston, Christopher Morash, John P Logue, Chris Parker, Rachel C Morgan
Publikováno v:
BJU international. 99(6)
Radiotherapy and androgen deprivation in combination after local surgery (RADICALS): A new Medical Research Council/National Cancer Institute of Canada phase III trial of adjuvant treatment after radical prostatectomy Chris Parker, Matthew R. Sydes 1
Autor:
Matthew R. Sydes, David P. Dearnaley, Richard A Cowan, Lesley Fallowfield, Sharon L. Naylor, Richard Stephens
Publikováno v:
BJU international. 99(2)
OBJECTIVE: To explore patients’ quality of life (QoL) during neoadjuvant hormone therapy (HT) using data from the Medical Research Council RT01 trial of standard- (64 Gy/32-fraction) and high- (74 Gy/37-fraction) dose radiotherapy (RT, both given c